NKNavjyot Kaur

Navjyot Kaur

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Navjyot Kaur has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Macroscopic T Wave Alternans in a Patient with Rheumatic Heart Disease

    by Navjyot Kaur, Rahil Arora, Rajeev Chauhan, Ajay Swamy

    A middle-aged lady in her late forties and a known case of rheumatic heart disease presented with acute decompensated heart failure. On admission, she was found to have atrial fibrillation with fast ventricular rate. She was initially managed with mechanical ventilation, diuretics, and parenteral amiodarone. During admission, she had two episodes of ventricular tachycardia at 12 h interval for which she was electro-cardioverted. Post-cardioversion, she developed giant and deep T waves with macroscopic T wave alternans which is a harbinger of further malignant arrhythmias. She was managed conservatively, and she responded well to the treatment. We intend to present this rare electrocardiographic repolarization abnormality and its reversal to normal T waves and QT interval as the patient improved.

  • Open Access

    Pulmonary Arteriovenous Malformation in a Young Man

    by Navjyot Kaur, Rajeev Chauhan, Ajay J. Swamy

    A young man was diagnosed to have pulmonary arteriovenous malformation (PAVM) when he was admitted with COVID infection. He had no respiratory distress but his saturation at room air was 90%. Chest X-ray revealed non-homogenous opacity in left lower lobe (LLL). The heart was structurally normal on 2D echocardiography; the saline bubble study was however positive for extra-cardiac shunt. Computed tomography pulmonary angiography (CTPA) revealed PAVM with well-defined lobulated sac measuring 2.9 × 1.9 × 2.5 cm in lateral basal segment of LLL with segmental branch of left pulmonary artery as feeder vessel and it drained into left pulmonary vein. The patient was managed with percutaneous intervention using Amplatzer Vascular Plug II to occlude the feeder vessel. Post-intervention, patient’s saturation improved to 98% at room air and saline bubble study was negative for extra-cardiac shunt. CTPA at 06 weeks revealed complete thrombosis of the sac.


  • Open Access

    The Safety and Long-Term Efficacy of Carotid Artery Stenting: An All-Comers Registry

    by Ratheesh Kumar, Davinder Chadha, Amitoj Chaddha, Rajeev Chauhan, Navreet Singh, Pathak Kamal, Atul Mishra, Navjyot Kaur

    Carotid artery stenting (CAS) has emerged as a less invasive alternative to carotid endarterectomy (CEA) for the prevention of future cerebrovascular events in patients with carotid artery stenosis. Despite multiple randomized controlled trials (RCTs) comparing CAS and CEA for carotid disease, real-world data outside the rigorous environment of trials is scarce. The present study is a prospective observational study conducted at a tertiary care center, wherein all patients who underwent CAS between January 2007 and December 2019 were included. All patients were followed up for one year of the last enrolled patient at an interval of one, six, and 12 months and then yearly thereafter. The primary composite outcome was defined as a combination of periprocedural (until 30 days of procedure) major adverse cardiac and cerebrovascular events (MACCEs) and the long-term incidence of ipsilateral stroke. The secondary outcome included the rate of restenosis. A total of 115 patients (86 males and 29 females) (147 lesions) who underwent CAS between 2007 and 2019 were followed up for a median of 80.5 months. Seventy-seven (67.27%) patients were symptomatic, and 38/115 (33%) were asymptomatic. Periprocedural MACCEs were noted in six patients, and four patients had ipsilateral stroke on long-term follow-up; hence, the primary composite outcome was observed in 10 (8.7%) patients. Higher age was found to be significantly associated with the primary composite outcome (p-value = 0.005). Five (4.34%) patients were lost to follow-up, while four (3.48%) patients developed restenosis. CAS is a safe and less invasive intervention in patients with significant carotid artery stenosis and is equally effective in preventing future strokes. The incidence of primary outcome rises with an increase in age.


  • Open Access

    Delay in Seeking Medical Treatment Among Patients With Acute Coronary Syndrome

    by Prashant Panda, Neena Vir Singh, Navjyot Kaur, Prabhjot Kaur, Avneet Kaur, Harleen Kaur Aujla, Khushpreet Kaur, Nishtha Saini, Shakshi Kapoor, Yash Paul Sharma

    Various Indian registries have documented a delay of more than five hours for acute coronary syndrome patients from onset of symptoms to reaching thrombolysis-enabled centres. We conducted this study to evaluate the factors responsible for pre-hospital delay in acute coronary syndrome patients. This was a descriptive cross-sectional study conducted in consecutive acute coronary syndrome patients who reported to the tertiary care medical centre in North India. A standardized tool was used to record the demographic data, socioeconomic status and clinical presentation of patients. All factors which led to pre-hospital delay were noted and the appropriate statistical tests were used for analysis. A total of 130 patients (males=93, females=37) were included in the study. The median time at which the acute coronary syndrome patients presented to the thrombolysis and percutaneous coronary intervention enabled centre was 490 minutes (range: 20 - 810 minutes) and 710 minutes (range: 45 - 940 minutes) respectively. The various factors responsible for prehospital delay were rural residence (p-value <0.0001), visit to local dispensary (p-value=0.0023), delay in getting transport (p-value=0.03) and misinterpretation of cardiac symptoms (p-value=0.0004). A significant but weak negative correlation was found between per capita income, decision making time and time taken to receive thrombolytic therapy. Out of a total of 83 ST-elevation myocardial infarction patients, only 46 (51.80%) were thrombolysed. Though 69/83 (83.13%) ST-elevation myocardial infarction patients reached thrombolysis enabled centre directly, only nine (10.84%) were thrombolysed at first medical contact; the rest were transferred to the percutaneous coronary intervention-enabled centre without any prior information. Our study concludes that besides socioeconomic and demographic variables, lack of public awareness, well established public transport & health insurance system lead to significant pre-hospital delays and increase the time to revascularization. Besides, judgemental error on the part of medical practitioners in the peripheries also significantly delays thrombolysis in ST-elevation myocardial infarction patients.


  • Open Access

    Tophaceous gout in uncorrected cyanotic congenital heart disease

    by Himanshu Gupta, Navjyot Kaur, Kewal Chand Goswami

    A 23-year-old man, a known case of uncorrected severe tetralogy of fallot with pulmonary atresia, presented to us with painful swellings of bilateral first metatarsophalangeal joints and interphalangeal joint of right middle finger. On examination, he was cyanosed with a resting oxygen saturation of 84% on room air and had grade IV clubbing (figure 1A). Large tophi could be seen at base of both great toes and interphalangeal joint of right middle finger, along with few tophi with spontaneous skin ulceration at ankles and planter aspects of both feet (figure 1A–D). The patient had haemoglobin of 200 g/L and uric acid was 7.8 mg/dL. His urea and creatinine were 39 mg/dL and 0.9 mg/dL, respectively, and estimated glomerular filtration rate was 111.1 mL/min/1.73 m2. Other biochemical parameters including potassium (5.1 mEq/L) and lactate dehydrogenase levels (270 U/L) were within normal limits. His urine examination revealed mild proteinuria (200 mg/24 hours). He was managed with colchicine and non-steroidal anti-inflammatory drugs (NSAIDs) for acute gout and was subsequently started on allopurinol. He has been doing well on follow-up with no further flares of acute gout.


  • Antitubercular therapy induced liver function tests abnormalities in human immunodeficiency virus infected individuals

    by Pankaj Puri, Navjyot Kaur, Sunny Pathania, Sandeep Kumar, P.K. Sharma, V.K. Sashindran


  • Open Access

    Proteomic analysis of human osteoarthritis synovial fluid

    by Lavanya Balakrishnan, Raja Sekhar Nirujogi, Sartaj Ahmad, Mitali Bhattacharjee, Srikanth S Manda, Santosh Renuse, Dhanashree S Kelkar, Yashwanth Subbannayya, Rajesh Raju, Renu Goel, et al.

    Background: Osteoarthritis is a chronic musculoskeletal disorder characterized mainly by progressive degradation of the hyaline cartilage. Patients with osteoarthritis often postpone seeking medical help, which results in the diagnosis being made at an advanced stage of cartilage destruction. Sustained efforts are needed to identify specific markers that might help in early diagnosis, monitoring disease progression and in improving therapeutic outcomes. We employed a multipronged proteomic approach, which included multiple fractionation strategies followed by high resolution mass spectrometry analysis to explore the proteome of synovial fluid obtained from osteoarthritis patients. In addition to the total proteome, we also enriched glycoproteins from synovial fluid using lectin affinity chromatography. Results: We identified 677 proteins from synovial fluid of patients with osteoarthritis of which 545 proteins have not been previously reported. These novel proteins included ADAM-like decysin 1 (ADAMDEC1), alanyl (membrane) aminopeptidase (ANPEP), CD84, fibulin 1 (FBLN1), matrix remodelling associated 5 (MXRA5), secreted phosphoprotein 2 (SPP2) and spondin 2 (SPON2). We identified 300 proteins using lectin affinity chromatography, including the glycoproteins afamin (AFM), attractin (ATRN), fibrillin 1 (FBN1), transferrin (TF), tissue inhibitor of metalloproteinase 1 (TIMP1) and vasorin (VSN). Gene ontology analysis confirmed that a majority of the identified proteins were extracellular and are mostly involved in cell communication and signaling. We also confirmed the expression of ANPEP, dickkopf WNT signaling pathway inhibitor 3 (DKK3) and osteoglycin (OGN) by multiple reaction monitoring (MRM) analysis of osteoarthritis synovial fluid samples. Conclusions: We present an in-depth analysis of the synovial fluid proteome from patients with osteoarthritis. We believe that the catalog of proteins generated in this study will further enhance our knowledge regarding the pathophysiology of osteoarthritis and should assist in identifying better biomarkers for early diagnosis.


  • Open Access

    Differential proteomic analysis of synovial fluid from rheumatoid arthritis and osteoarthritis patients

    by Lavanya Balakrishnan, Mitali Bhattacharjee, Sartaj Ahmad, Raja Sekhar Nirujogi, Santosh Renuse, Yashwanth Subbannayya, Arivusudar Marimuthu, Srinivas M Srikanth, Rajesh Raju, Mukesh Dhillon, et al.

    Background: Rheumatoid arthritis and osteoarthritis are two common musculoskeletal disorders that affect the joints. Despite high prevalence rates, etiological factors involved in these disorders remain largely unknown. Dissecting the molecular aspects of these disorders will significantly contribute to improving their diagnosis and clinical management. In order to identify proteins that are differentially expressed between these two conditions, a quantitative proteomic profiling of synovial fluid obtained from rheumatoid arthritis and osteoarthritis patients was carried out by using iTRAQ labeling followed by high resolution mass spectrometry analysis.Results: We have identified 575 proteins out of which 135 proteins were found to be differentially expressed by ≥3-fold in the synovial fluid of rheumatoid arthritis and osteoarthritis patients. Proteins not previously reported to be associated with rheumatoid arthritis including, coronin-1A (CORO1A), fibrinogen like-2 (FGL2), and macrophage capping protein (CAPG) were found to be upregulated in rheumatoid arthritis. Proteins such as CD5 molecule-like protein (CD5L), soluble scavenger receptor cysteine-rich domain-containing protein (SSC5D), and TTK protein kinase (TTK) were found to be upregulated in the synovial fluid of osteoarthritis patients. We confirmed the upregulation of CAPG in rheumatoid arthritis synovial fluid by multiple reaction monitoring assay as well as by Western blot. Pathway analysis of differentially expressed proteins revealed a significant enrichment of genes involved in glycolytic pathway in rheumatoid arthritis.Conclusions: We report here the largest identification of proteins from the synovial fluid of rheumatoid arthritis and osteoarthritis patients using a quantitative proteomics approach. The novel proteins identified from our study needs to be explored further for their role in the disease pathogenesis of rheumatoid arthritis and osteoarthritis.Sartaj Ahmad and Raja Sekhar Nirujogi contributed equally to this article.